NGS Reference Standards

NGS technology is widely used in drug discovery and translational medicine, such as determining individual genome sequences and confirming mutations associated with genetic diseases and somatic mutations in tumour cells. GeneCopoeia provides both NGS Reference Standards and NGS Spike-in Reference Standards.

 
OncoSpot™ NGS
Reference Standards
GeneCopoeia’s OncoSpot™ NGS Reference Standards use highly characterized HCT116 cell lines, genetically modified with advanced genome editing technology to include clinically relevant cancer gene mutations.
 
OncoSpot™ NGS Spike-in Reference Standards GeneCopoeia provides OncoSpot™ NGS Spike-in Reference Standards for monitoring the entire process of detection.